Skip to main content

Table 1 Clinical characteristics of systemic disease in SCNSL patients

From: Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study

Characteristics N %
Age
 Median (range) 58 (20–72)  
 ≤ 60 10 52.6
 > 60 9 47.4
Gender
 Male 9 47.4
 Female 10 52.6
Initial disease location
 Breasts 3 15.8
 Testis 2 10.5
 Lymph node 11 57.9
 Others 3 15.9
Ann Arbor stage
 I–II 5 26.3
 III–IV 14 73.7
Treatment of initial disease
 R-CHOP like regimen 9 47.4
 Other regimen 10 52.6
CNS prophylaxis
 Yes 2 10.5
 No 17 89.5